An asymmetric total synthesis of (−)-fumagillol (cas 108102-51-8)
-
Add time:08/23/2019 Source:sciencedirect.com
(−)-Fumagillol (2), a hydrolysis product of fumagillin (1), has been synthesized in a highly stereoselective manner utilizing a glycolate Claisen rearrangement and an intramolecular ester enolate alkylation as key steps starting from carbohydrate-based precursor 5.
We also recommend Trading Suppliers and Manufacturers of fumagillol (cas 108102-51-8). Pls Click Website Link as below: cas 108102-51-8 suppliers
Prev:Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol (cas 108102-51-8)
Next:Investigative UrologyAntitumor Effects of Angiogenesis Inhibitor O-(Chloroacetyl-Carbamoyl) fumagillol (cas 108102-51-8) (TNP-470) against Murine Renal Cell Carcinoma) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (cas 108102-51-8) (TNP-470; AGM-1470)08/25/2019
- Investigative UrologyAntitumor Effects of Angiogenesis Inhibitor O-(Chloroacetyl-Carbamoyl) fumagillol (cas 108102-51-8) (TNP-470) against Murine Renal Cell Carcinoma08/24/2019
- Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol (cas 108102-51-8)08/22/2019
- Stereoselective formal synthesis of (-)-fumagillol (cas 108102-51-8)08/21/2019
